on 30 Jan 2024
Last Applicant/ Owned by
London NW1 2ND
GB
Serial Number
79345480 filed on 25th Feb 2022
Registration Number
7292296 registered on 30th Jan 2024
Correspondent Address
Bruce S. Londa Norris McLaughlin, P.A.
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
Drug discovery and pharmaceutical drug development services; scientific services, namely, research in the field of pharmaceuticals, and new product development and design relating thereto; medical research; technological services, namely, research in the field of pharmaceuticals, and new product design relating thereto; new product design and development of medical technology; new product design aRead More
Medical services; medical diagnostic testing services and prognostic medical services in the nature of medical consultations; veterinary services; medical analysis services relating to the treatment of persons; pharmaceutical advice; medical and health counseling services relating to antibodies, immuno-oncology, inflammation, haematology and infectious disease; medical screening and assaying in the nature of medical testing for diagnostic or treatment purposes
11th 000101
11th 000101
Drug discovery and pharmaceutical drug development services; scientific services, namely, research in the field of pharmaceuticals, and new product development and design relating thereto; medical research; technological services, namely, research in the field of pharmaceuticals, and new product design relating thereto; new product design and development of medical technology; new product design and development of medical diagnostic apparatus; consultancy services relating to development of new technology for others in the field of pharmaceuticals and medical technology; industrial analysis, namely, consulting services in the field of industrial engineering; industrial research in the field of pharmaceuticals and medical technology; design and development of computer hardware and software; clinical research in the field of antibodies, immuno-oncology, inflammation, haematology and infectious disease; pharmaceutical research and development; development of pharmaceutical preparations and medicines; research and development services in the field of antibodies, immuno-oncology, inflammation, haematology and infectious disease; scientific research in the nature of conducting clinical trials for others; scientific research in the nature of conducting clinical trials for pharmaceutical products; scientific screening and assaying in the nature of providing reagent sample testing and diagnostic services for others for scientific research purposes; chemical analysis; chemical research; biotechnology research; consultancy relating to biotechnology
11th 000101
11th 000101
Pharmaceutical preparations for cancer and neurological diseases for medical and veterinary use; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary use; dietary supplements for human beings and animals; dietary supplements; pharmaceutical preparations for use in oncology
11th 000101
11th 000101
Chemicals for use in biotechnological product development; chemicals for use in biotechnological manufacturing processes; chemical preparations in the nature of biologically compatible chemical substances for scientific purposes other than for medical or veterinary use, namely, scientific, laboratory, clinical and medical research; biological tissue, namely, mammalian soft and hard tissues comprising or derived from stem cells or progenitor cells for scientific, laboratory, clinical and medical research; biological tissue, namely, biological tissue comprising or derived from stem cells or progenitor cells, and compositions thereof, for scientific, laboratory, clinical and medical research
11th 000101
11th 000101
No 79345480
No Service Mark
No 116940-79
No
No
No
No
Yes
Yes
No
No
| Status Date | Action Taken |
|---|---|
| 01st May 2024 | FINAL DISPOSITION PROCESSED |
| 01st May 2024 | FINAL DISPOSITION NOTICE SENT TO IB |
| 30th Apr 2024 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| 30th Jan 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 30th Jan 2024 | REGISTERED-PRINCIPAL REGISTER |
| 13th Jan 2024 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| 27th Dec 2023 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| 27th Dec 2023 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| 14th Nov 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 14th Nov 2023 | PUBLISHED FOR OPPOSITION |
